多菌型麻风患者联合化疗6个月后停药随访7年结果分析  被引量:3

Analysis on Results of Seven Year Following up among Multibacillary Patients Treated with Multidrug Therapy for Six Months

在线阅读下载全文

作  者:沈建平[1] 严良斌[1] 余美文[1] 李进岚[2] 余秀峰 

机构地区:[1]中国医学科学院北京协和医学院皮肤病研究所,江苏南京210042 [2]贵州省疾病预防控制中心,贵州贵阳550004 [3]文山州皮肤病防治研究所,云南文山663000

出  处:《皮肤性病诊疗学杂志》2014年第3期181-184,共4页Journal of Diagnosis and Therapy on Dermato-venereology

基  金:世界卫生组织项目(编号:L42/181/192)

摘  要:目的:分析多菌型麻风患者经过6个月联合化疗后停药,随访7年的结果。方法:对新发或复发未经治疗的多菌型麻风患者给予WHO联合化疗多菌型方案治疗6个月,停药后观察7年,评价临床和细菌学疗效。结果:共收录多菌型麻风患者114例,中途退出43例,71例纳入分析。疗前患者平均细菌指数为2.93±1.39,停药满7年时所有患者细菌指数阴转,平均年下降0.42。7年中共观察到麻风反应38人次,反应频率为53.5%。有1例在停药13个月时复发,复发率为0.05/100人年。结论:多菌型麻风患者6个月联合化疗有效。联合化疗6个月患者的细菌指数变化和麻风反应与报告的经1年或2年联合化疗的多菌型患者情况相似。To analyze the results of treatment among MB patients 7 years after trea-ted with six months’ multidrug therapy.Methods:Newly detected and relapsed MB leprosy pa-tients were treated with 6 months’ WHO multidrug therapy.Then the patients were followed up for 7 years.The effectiveness of treatment was analyzed by clinical status and bacteriological studies. Results:A total of 114 patients were recruited.43 patients were withdrawn from the study.Only 71 patients were qualified for analysis.The mean bacteriological index ( BI ) of all patients de-creased from 2.93 ±1.39 before treatment to 0 at the end of seventh year’ following up with annu-al BI decrease of 0.42 .The rate of smear negativity of all patients was 100%at the end of seven year’ following up.There were 38 leprosy reactions observed during the study with a rate of 53.5%and one patient relapsed with a relapse rate of 0.05 per 100 patient year.Conclusion:Multidrug therapy for 6 months was effective in MB patients, the frequencies for decreased BI and leprosy reactions were similar to those accepted the therapy for 1 or 2 years.

关 键 词:麻风 联合化疗 细菌指数 麻风反应 

分 类 号:R755[医药卫生—皮肤病学与性病学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象